XNAS: CVKD
Cadrenal Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
Cadrenal Therapeutics Inc is a late-stage biopharmaceutical company advancing novel therapies for life-threatening immune and thrombotic conditions. Its product candidate, CAD-1005, is a first-in-class selective 12-LOX inhibitor being developed to tr...
Read More
2.16
-0.17
(-7.30%)
46,551
XNAS Volume
XNAS 17 Jul, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
Cadrenal Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..